Read + Share
Amedeo Smart
Independent Medical Education
Greene SJ, Corda S, McMullan CJ, Palombo G, et al. Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: The VELOCITY study. Eur J Heart Fail 2025 May 19. doi: 10.1002/ejhf.3699.PMID: 40389233
Email
LinkedIn
Privacy Policy